Article (Scientific journals)
Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa.
Muller, Marie; Broséus, Julien; Guilloteau, Adrien et al.
2023In Journal of Crohn's and Colitis
Peer Reviewed verified by ORBi
 

Files


Full Text
jjad177.pdf
Author postprint (787.58 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Crohn’s disease; inflammatory bowel disease; lymphoma; prognosis
Abstract :
[en] [en] BACKGROUND: IBD is associated with an increased risk of developing lymphoma. Although recent data clarifies lymphoma epidemiology in IBD patients, clinical and pathological characteristics of lymphoma occurring in IBD remain ill-known. METHODS: Patients with IBD and lymphoma were retrospectively identified in the framework of a national collaborative study including the Groupe d'Étude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID) and the Lymphoma Study Association (LYSA). We characterized clinical and prognostic features for the 3 most frequent lymphoma subtypes occurring in IBD. We performed a multicentric case-control study. Controls (lymphoma de novo) were matched (5:1) to cases on gender, age at diagnosis, lymphoma subtype, year of diagnosis, IPI/FLIPI indexes. Overall survival (OS) and progression free survival were compared between cases and controls. RESULTS: 133 IBD patients with lymphoma were included (males = 62.4 %, median age at lymphoma diagnosis = 49 years in males ; 42 in females). Most had Crohn's disease (73.7 %) and were exposed to thiopurines (59.4 %). The most frequent lymphoma subtypes were diffuse large B cell lymphoma (DLBCL, 45.1 %), Hodgkin lymphoma (HL, 18.8 %), and follicular lymphoma (FL, 10.5 %). When matched with 365 controls, prognosis was improved in IBD patients with DLBCL compared to controls (p = 0.0064, hazard ratio = 0.36) or similar (HL and FL). CONCLUSION: Lymphomas occurring in IBD patients do not seem to have a worse outcome than in patients without IBD. Due to the scarcity of this situation, those patients should be managed in expert centers.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Muller, Marie ;  Department of Gastroenterology, Nancy University Hospital, University of Lorraine, Nancy, France
Broséus, Julien;  University of Lorraine, Inserm U1256 « Nutrition - Genetics and exposure to environmental risks - NGERE », F-54000, Nancy, France ; University of Lorraine, CHRU-Nancy Hematology Laboratory, Laboratory department, F-54000 Nancy, France
Guilloteau, Adrien;  Registre des hemopathies Malignes de Côte d'Or, Inserm U1231, University of Burgundy and Dijon University Hospital, Dijon, France
Wasse, Stéphane;  Registre des hemopathies Malignes de Côte d'Or, Inserm U1231, University of Burgundy and Dijon University Hospital, Dijon, France
Thiéblemont, Catherine;  AP-HP, Saint-Louis Hospital, Hemato-oncology, University of Paris, Paris, France
Nancey, Stéphane;  Department of Gastroenterology, University Claude Bernard Lyon 1, Hospices Civils de Lyon, CHU Lyon-Sud, Lyon, France
Cadiot, Guillaume;  Department of Hepato-Gastro-Enterology, Reims University Hospital, France
Amiot, Aurélien;  Department of Gastroenterology, Henri Mondor University Hospital, AP-HP, Paris Est Créteil University, Créteil, France
Laharie, David;  Department of Hepato-Gastro-Enterology, Bordeaux University Hospital, Pessac, France
Vieujean, Sophie  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de gastroentérologie, hépatologie, onco. digestive
Bouhnik, Yoram;  Institut National de la Santé et Recherche Médicale et Université Paris Diderot, Paris Hôpital Beaujon, AP-HP, Paris, France
Martineau, Chloé;  Department of Gastroenterology, Hôpital Européen George Pompidou, AP-HP, Paris, France
Michiels, Christophe;  Department of Hepato-Gastro-Enterology, Dijon University Hospital, France
Hebuterne, Xavier;  Department of Hepato-Gastro-Enterology, Nice University Hospital, France
Savoye, Guillaume;  Department of Hepato-Gastro-Enterology, Rouen University Hospital, France
Franchimont, Denis;  Department of Hepato-Gastro-Enterology, Erasme University Hospital, Brussels, Belgium
Seksik, Philippe;  Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Saint-Antoine, Department of Gastroenterology, F75012, Paris, France
Beaugerie, Laurent;  Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Saint-Antoine, Department of Gastroenterology, F75012, Paris, France
Maynadié, Marc;  Registre des hemopathies Malignes de Côte d'Or, Inserm U1231, University of Burgundy and Dijon University Hospital, Dijon, France
Feugier, Pierre;  University of Lorraine, Inserm U1256 « Nutrition - Genetics and exposure to environmental risks - NGERE », F-54000, Nancy, France ; Department of Clinical Hematology, Nancy University Hospital, University of Lorraine, Nancy, France
Peyrin-Biroulet, Laurent;  Department of Gastroenterology, Nancy University Hospital, University of Lorraine, Nancy, France ; University of Lorraine, Inserm U1256 « Nutrition - Genetics and exposure to environmental risks - NGERE », F-54000, Nancy, France
More authors (11 more) Less
Language :
English
Title :
Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa.
Publication date :
18 October 2023
Journal title :
Journal of Crohn's and Colitis
ISSN :
1873-9946
eISSN :
1876-4479
Publisher :
Oxford University Press (OUP), England
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 27 October 2023

Statistics


Number of views
5 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

OpenCitations
 
0

Bibliography


Similar publications



Contact ORBi